Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Australas J Dermatol ; 64(3): e256-e261, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37154242

RESUMO

We present a case of a 66-year-old man with a cutaneous Balamuthia mandrillaris lesion that progressed to fatal granulomatous amoebic encephalitis. We provide a summary of Australian cases and describe the clinical features and approach to diagnosing this rare but devastating condition, including the importance of PCR for diagnosis.


Assuntos
Amebíase , Balamuthia mandrillaris , Encefalite Infecciosa , Humanos , Masculino , Idoso , Amebíase/diagnóstico , Encefalite Infecciosa/diagnóstico , Evolução Fatal , Biópsia , Pele/patologia , Antiprotozoários/uso terapêutico , Fluconazol/uso terapêutico
2.
Australas J Dermatol ; 63(3): 380-384, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35500145

RESUMO

We present a case of a neonate who presented with multiple cutaneous and subcutaneous nodules, which was found to be metastatic embryonal rhabdomyosarcoma. Rhabdomyosarcoma is a soft tissue malignancy that usually occurs in children aged one to five but is rare in neonates. The histopathological analysis and molecular genetics are important in the classification of subtype and in guiding treatment options and informing prognosis.


Assuntos
Rabdomiossarcoma Embrionário , Rabdomiossarcoma , Criança , Humanos , Recém-Nascido , Biologia Molecular , Prognóstico , Rabdomiossarcoma/genética , Rabdomiossarcoma/patologia , Rabdomiossarcoma/terapia , Rabdomiossarcoma Embrionário/genética , Rabdomiossarcoma Embrionário/terapia
3.
PLoS Negl Trop Dis ; 15(9): e0009751, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34591843

RESUMO

Scabies has recently gained international attention, with the World Health Organization (WHO) recognizing it as a neglected tropical disease. The International Alliance for the Control of Scabies recently formed as a partnership of more than 15 different countries, with an aim to lead a consistent and collaborative approach to preventing and controlling scabies globally. Scabies is most prevalent in low-resource and low socioeconomic areas that experience overcrowding and has a particularly high prevalence in children, with an estimated 5% to 10% in endemic countries. Scabies is widespread in remote Aboriginal and Torres Strait Islander communities in Australia with the prevalence of scabies in Aboriginal and Torres Strait Islander children in remote communities estimated to be as high as 33%, making it the region with the third highest prevalence in the world. This population group also have very high rates of secondary complications of scabies such as impetigo, poststreptococcal glomerulonephritis (PSGN), and rheumatic heart disease (RHD). This article is a narrative review of scabies in remote Aboriginal and Torres Strait Islander populations in Australia, including clinical manifestations of disease and current treatment options and guidelines. We discuss traditional approaches to prevention and control as well as suggestions for future interventions including revising Australian treatment guidelines to widen the use of oral ivermectin in high-risk groups or as a first-line treatment.


Assuntos
Demografia , Havaiano Nativo ou Outro Ilhéu do Pacífico , Escabiose/epidemiologia , Antiparasitários/uso terapêutico , Austrália/epidemiologia , Humanos , Ivermectina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...